Can magnetic resonance spectroscopy differentiate malignant and benign causes of lymphadenopathy? An in-vitro approach
Fig 3
Blinded test set loaded in model predicting benign and malignant tissues.
New benign and malignant samples not previously analyzed were blindly loaded into the OPLS-DA model from Fig 2, and the categories were subsequently revealed. t1 and t1o are the same as in Fig 2.